Rick E Winningham
2015 - Theravance Biopharma
In 2015, Rick E Winningham earned a total compensation of $5.5M as Chief Executive Officer at Theravance Biopharma, a 63% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $271,064 |
|---|---|
| Salary | $902,069 |
| Stock Awards | $4,325,000 |
| Other | $814 |
| Total | $5,498,947 |
Winningham received $4.3M in stock awards, accounting for 79% of the total pay in 2015.
Winningham also received $271.1K in non-equity incentive plan, $902.1K in salary and $814 in other compensation.
Rankings
In 2015, Rick E Winningham's compensation ranked 1,409th out of 13,638 executives tracked by ExecPay. In other words, Winningham earned more than 89.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,409 out of 13,638 | 90th |
Division Manufacturing | 494 out of 5,187 | 91st |
Major group Chemicals And Allied Products | 182 out of 1,857 | 90th |
Industry group Drugs | 140 out of 1,531 | 91st |
Industry Pharmaceutical Preparations | 115 out of 1,179 | 90th |
Source: SEC filing on March 25, 2016.
Winningham's colleagues
We found three more compensation records of executives who worked with Rick E Winningham at Theravance Biopharma in 2015.
News
Theravance Biopharma CEO Rick Winningham's 2023 pay falls 31% to $4.3M
April 5, 2024
Theravance Biopharma CEO Rick Winningham's 2020 pay rises 11% to $6.6M
March 22, 2021
Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
March 24, 2020
Theravance Biopharma Former Senior Vice President, Corporate Development and Strategy Shehnaaz Suliman's 2018 pay falls 35% to $2.7M
March 20, 2019